{
    "organizations": [],
    "uuid": "d2e5d56df384e7916d939c62c64b4c54e9e9bd62",
    "author": "",
    "url": "https://www.reuters.com/article/brief-vtv-therapeutics-says-phase-1b-stu/brief-vtv-therapeutics-says-phase-1b-study-of-ttp399-for-the-treatment-of-type-1-diabetes-completed-idUSFWN1R413B",
    "ord_in_thread": 0,
    "title": "BRIEF-vTv Therapeutics Says Phase 1B Study Of TTP399 For The Treatment Of Type 1 Diabetes Completed",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 22, 2018 / 9:43 PM / Updated 11 minutes ago BRIEF-vTv Therapeutics Says Phase 1B Study Of TTP399 For The Treatment Of Type 1 Diabetes Completed Reuters Staff 1 Min Read   vTv Therapeutics Inc: * VTV THERAPEUTICS ANNOUNCES COMPLETION OF PHASE 1B STUDY EVALUATING TTP399 FOR THE TREATMENT OF TYPE 1 DIABETES Source text for Eikon:  ",
    "published": "2018-03-22T23:40:00.000+02:00",
    "crawled": "2018-03-22T23:57:43.033+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "say",
        "phase",
        "1b",
        "study",
        "ttp399",
        "treatment",
        "type",
        "diabetes",
        "completed",
        "reuters",
        "staff",
        "min",
        "read",
        "vtv",
        "therapeutic",
        "inc",
        "vtv",
        "therapeutic",
        "announces",
        "completion",
        "phase",
        "1b",
        "study",
        "evaluating",
        "ttp399",
        "treatment",
        "type",
        "diabetes",
        "source",
        "text",
        "eikon"
    ]
}